We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO

News   Jul 19, 2018 | Original story from UCL Technology Fund

 
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO
 
 
 

RELATED ARTICLES

No Cancer Risk for Telomerase Gene Therapy

News

Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.

READ MORE

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

Microfluidically-linked BBB and Brain-chips Opens Another Dimension for Neurological Research

News

Linked BBB and brain-chips strike the perfect balance of complexity and simplicity for studying the neurovascular unit.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics Drug Discovery Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE